Apoptotic pathways in the pathogenesis of pemphigus: targets for new therapies

Curr Pharm Biotechnol. 2012 Aug;13(10):1877-81. doi: 10.2174/138920112802273236.

Abstract

Pemphigus is a group of rare autoimmune blistering diseases of the skin in which autoantibodies to desmosome cadherins, desmogleins, induce loss of cell-cell adhesion (acantholysis). In addition to steric hindrance and activation of intracellular phosphorylation cascade signaling pathways, apoptosis has been suggested to contribute to the mechanism by which pathogenic IgG induces acantholysis. We review the literature examining the role of apoptosis in pemphigus. Current data recognize a central role of apoptosis in the mechanisms of blister induction. In particular, here we stress the key role of FasL in pemphigus, as it is able to first induce apoptosis, then acantholysis. Being pro-apoptotic molecules important in blister formation, they could represent new specific targets for pemphigus treatment.

Publication types

  • Review

MeSH terms

  • Acantholysis / drug therapy*
  • Acantholysis / etiology
  • Acantholysis / immunology
  • Acantholysis / pathology*
  • Animals
  • Apoptosis / drug effects*
  • Apoptosis / immunology
  • Autoantibodies / blood
  • Autoantibodies / immunology
  • Fas Ligand Protein / immunology
  • Fas Ligand Protein / metabolism
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / adverse effects
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunoglobulin G / immunology
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Keratinocytes / drug effects
  • Keratinocytes / immunology
  • Keratinocytes / pathology
  • Molecular Targeted Therapy*
  • Pemphigus / complications
  • Pemphigus / drug therapy*
  • Pemphigus / immunology
  • Pemphigus / pathology*
  • fas Receptor / immunology
  • fas Receptor / metabolism

Substances

  • Autoantibodies
  • Fas Ligand Protein
  • Glucocorticoids
  • Immunoglobulin G
  • Immunosuppressive Agents
  • fas Receptor